<DOC>
	<DOCNO>NCT01779973</DOCNO>
	<brief_summary>The goal project test feasibility , acceptability , preliminary efficacy use remote compliance monitoring buprenorphine ( Suboxone® ) treatment opiate dependence . To end , 10 opiate dependent subject recruit University Pennsylvania 's Treatment Research Center , outpatient substance abuse treatment facility . All subject receive buprenorphine ( Suboxone® ) ( 16 mg/day , adjust need accord individual requirement ) .</brief_summary>
	<brief_title>Remote Observed Dosing Increase Suboxone Compliance</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<criteria>Voluntarily provide write informed consent prior conduct studyrelated procedure Male female , 18 65 year age , Meet DSMIV criterion current opioid dependence Females childbearing potential fertile male must use reliable mean contraception Owns smartphone forward face camera allow use Skype University Pennsylvania student , employee , affiliate Current diagnosis AIDS Presence AST and/or ALT equal 3X upper limit normal Total bilirubin and/or creatinine equal 1.5X upper limit normal Current diagnosis chronic pain require opioids Pregnant lactate female Previous hypersensitivity allergy buprenorphine EVAcontaining substance Current use agent metabolize CYP 3A4 azole antifungal ( e.g . ketoconazole ) , macrolide antibiotic ( e.g . erythromycin ) , protease inhibitor ( e.g . ritonavir , indinavir , saquinavir ) Meet DSMIV criterion current dependence psychoactive substance opioids nicotine ( e.g . alcohol , sedative ) Current use benzodiazepine physician prescribe Significant medical psychiatric symptom dementia opinion investigator would preclude compliance protocol , adequate cooperation study , obtain informed consent Concurrent medical condition ( severe respiratory insufficiency ) may prevent patient safely participate study ; and/or pending legal action could prohibit participation and/or compliance study procedure Participated clinical study within previous 8 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Skype</keyword>
	<keyword>compliance</keyword>
	<keyword>remote dose</keyword>
	<keyword>suboxone</keyword>
	<keyword>opiate</keyword>
	<keyword>opiate</keyword>
	<keyword>heroin</keyword>
	<keyword>oxycontin</keyword>
	<keyword>Philadelphia</keyword>
</DOC>